new glp 1 medication How GLP-1 medications are transforming diabetes and weight loss treatment Retatrutide for weight loss: Study

SteckelbroeckSNassenAUgeleBLudwigMWatzkaMReissingerAet al

However, due to the lack of operable industry standards and regulation, the abuse of anti-disease drugs (Wei et al., 2023)

In metformin-naive patients, similar reductions were observed (HR = 0.79, 95% CI 0.650.95, P = 0.01)

Substance-use disorders Pre-clinical and mechanistic studies A large body of pre-clinical and mechanistic literature is available regarding the putative effects of GLP-1RAs on substance misuse (Supplementary Section 5): 24 for alcohol 59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82 , 8 for opiates 63,83,84,85,86,87,88,89 , 16 for stimulants, including cocaine and amphetamines 90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105 , and 4 for nicotine 106,107,108,109

5.2 Interaction between dietary fiber and gut microbiota The human body cannot secrete the polysaccharide hydrolases required to decompose dietary fiber independently

Weakness and numbness in the hands and feet: Vitamin B12 deficiency can cause nerve damage, which can result in numbness or tingling in the hands and feet, as well as muscle weakness